Skip to main
SLGL
SLGL logo

Sol-Gel Technologies (SLGL) Stock Forecast & Price Target

Sol-Gel Technologies (SLGL) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 60%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Sol-Gel Technologies is experiencing growth in its new prescribers, with Epsolay and Twyneo recording increases of 6% and 5%, respectively, indicating a strengthening market presence. The company has achieved improved managed care coverage, with a notable increase of over 1 million commercial lives covered for Epsolay, bringing the total to 67.1 million. Additionally, the recent asset purchase agreement with Shenzhen Beimei Pharmaceutical Co. and revised revenue estimates for 2024 and 2025 highlight substantial potential for long-term growth through collaborations and market receptivity to its products.

Bears say

Sol-Gel Technologies Ltd. has experienced a significant decline in the market uptake of its key products, with total prescriptions for Twyneo decreasing by 23% in 1Q24 compared to the previous quarter, and patient refills dropping by 18%. The company's reported top-line revenue of $213,000 indicates a substantial miss against expectations, alongside concerns about continued revenue growth prospects due to challenges with gross-to-net discounting encountered by its partner, Galderma. Additionally, ongoing risks related to slow market adoption of both Twyneo and Epsolay, potential commercialization issues with Galderma, setbacks in other product developments, and possible dilution further compound the negative outlook for Sol-Gel Technologies's stock.

Sol-Gel Technologies (SLGL) has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 60% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sol-Gel Technologies and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sol-Gel Technologies (SLGL) Forecast

Analysts have given Sol-Gel Technologies (SLGL) a Buy based on their latest research and market trends.

According to 5 analysts, Sol-Gel Technologies (SLGL) has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.70, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.70, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sol-Gel Technologies (SLGL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.